Directa Plus plc , a producer and supplier of graphene-based products for use in consumer and industrial markets, announces that the United States Patent and Trademark Office has issued notification that it has granted the Company a patent covering its ‘flame retardant composition comprising graphene nanoplatelets’. Established in 2005, the Company has a patented technology process and a scalable and exportable manufacturing model. It produces graphene-based products at its own factory in Lomazzo, Italy, and can set up additional production at customer locations to reduce transport costs, waste and time-to-utilisation. Directa Plus partners with customers to enable them to offer the high-performance benefits of graphene in their own products.
The ability of Graphene Plus (G+) to confer flame retardancy on an object without the use of toxic chemicals is a key differentiator for Directa Plus, particularly for targeting the textiles market where manufacturers generally achieve flame retardancy through the addition of toxic chemicals to an object or the use of a chemical after-treatment. This is particularly relevant for workwear, such as for emergency services and manufacturing, and sportswear, such as motorsports.
The patent covers the product and the application of G+ nanoplatelets as a non-toxic, flame retardant additive and the application concerns the ability to use G+ to confer flame retardancy to a final object.
The grant of this patent gives Directa Plus a further competitive advantage and builds on previously received independent certifications that G+ textiles are non-irritating and safe for human skin. This includes a new hypoallergenic certification, received in December 2017, confirming that G+ textiles do not cause allergic reaction in human skin. The Company’s production process is chemical-free and this patent and the certifications are important differentiators for Directa Plus as well as being key requirements for some of the Company’s discussions within the textile industry as it continues the progress being made in the sector to capitalise on the opportunity for the widespread adoption of G+ materials in this target market.
The Company now has a portfolio of 16 patents granted and 16 pending. The majority of the granted patents relate to Directa Plus’ unique manufacturing process, along with some – including this latest patent – being product and application patents.